These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12379718)

  • 1. Protection against experimental Helicobacter pylori infection after immunization with inactivated H. pylori whole-cell vaccines.
    Raghavan S; Hjulström M; Holmgren J; Svennerholm AM
    Infect Immun; 2002 Nov; 70(11):6383-8. PubMed ID: 12379718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of mice against gastric colonization of Helicobacter pylori by therapeutic immunization with systemic whole cell inactivated vaccines.
    Suganya K; Prem Kumar A; Sekar B; Sundaran B
    Biologicals; 2017 Jan; 45():39-46. PubMed ID: 27843062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic immunization with unadjuvanted whole Helicobacter pylori protects mice against heterologous challenge.
    Harbour SN; Every AL; Edwards S; Sutton P
    Helicobacter; 2008 Dec; 13(6):494-9. PubMed ID: 19166414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis.
    Raghavan S; Svennerholm AM; Holmgren J
    Infect Immun; 2002 Aug; 70(8):4621-7. PubMed ID: 12117975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local secretory immunoglobulin A and postimmunization gastritis correlate with protection against Helicobacter pylori infection after oral vaccination of mice.
    Goto T; Nishizono A; Fujioka T; Ikewaki J; Mifune K; Nasu M
    Infect Immun; 1999 May; 67(5):2531-9. PubMed ID: 10225917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization.
    Akhiani AA; Stensson A; Schön K; Lycke N
    Scand J Immunol; 2006 Feb; 63(2):97-105. PubMed ID: 16476008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Th1 immunization of mice against Helicobacter pylori infection with CpG oligodeoxynucleotides as adjuvants does not protect from infection but enhances gastritis.
    Sommer F; Wilken H; Faller G; Lohoff M
    Infect Immun; 2004 Feb; 72(2):1029-35. PubMed ID: 14742550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice.
    Nyström J; Raghavan S; Svennerholm AM
    Microbes Infect; 2006 Feb; 8(2):442-9. PubMed ID: 16243563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant.
    Holmgren J; Nordqvist S; Blomquist M; Jeverstam F; Lebens M; Raghavan S
    Vaccine; 2018 Oct; 36(41):6223-6230. PubMed ID: 30119923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells.
    Akhiani AA; Pappo J; Kabok Z; Schön K; Gao W; Franzén LE; Lycke N
    J Immunol; 2002 Dec; 169(12):6977-84. PubMed ID: 12471132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with attenuated Salmonella typhimurium producing catalase in protection against gastric Helicobacter pylori infection in mice.
    Chen M; Chen J; Liao W; Zhu S; Yu J; Leung WK; Hu P; Sung JJ
    Helicobacter; 2003 Dec; 8(6):613-25. PubMed ID: 14632677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
    Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
    Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface expression of Helicobacter pylori HpaA adhesion antigen on Vibrio cholerae, enhanced by co-expressed enterotoxigenic Escherichia coli fimbrial antigens.
    Tobias J; Lebens M; Wai SN; Holmgren J; Svennerholm AM
    Microb Pathog; 2017 Apr; 105():177-184. PubMed ID: 28215587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background.
    Sutton P; Doidge C; Pinczower G; Wilson J; Harbour S; Swierczak A; Lee A
    FEMS Immunol Med Microbiol; 2007 Jul; 50(2):213-9. PubMed ID: 17567282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological response of recombinant H. pylori multi-epitope vaccine with different vaccination strategies.
    Wang B; Pan X; Wang H; Zhou Y; Zhu J; Yang J; Li W
    Int J Clin Exp Pathol; 2014; 7(10):6559-66. PubMed ID: 25400734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with recombinant FliD confers protection against Helicobacter pylori infection in mice.
    Ghasemi A; Mohammad N; Mautner J; Karsabet MT; Ardjmand A; Moniri R
    Mol Immunol; 2018 Feb; 94():176-182. PubMed ID: 29324238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The frequency of circulating integrin α4β7
    Akter S; Jeverstam F; Lundgren A; Magnusson MK; Walduck A; Qadri F; Bhuiyan TR; Raghavan S
    Helicobacter; 2019 Dec; 24(6):e12658. PubMed ID: 31502365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonization and immune responses in mice to Helicobacter pylori expressing different Lewis antigens.
    Suresh MR; Fanta MB; Kriangkum J; Jiang Q; Taylor DE
    J Pharm Pharm Sci; 2000; 3(2):259-66. PubMed ID: 10994038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of vaccination by a recombinant antigen ureB138 (a segment of the beta-subunit of urease) against Helicobacter pylori infection.
    Morihara F; Fujii R; Hifumi E; Nishizono A; Uda T
    J Med Microbiol; 2007 Jun; 56(Pt 6):847-853. PubMed ID: 17510273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses.
    Nyström J; Svennerholm AM
    Vaccine; 2007 Mar; 25(14):2591-8. PubMed ID: 17239498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.